Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lokesh Kumar Bhatt

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Inflammopharmacology|January 31, 2026
Cannabinoid type 2 receptor crosstalk and microglial plasticity-shaping the balance between neuroinflammation and repairShlok Bodke, Lokesh Kumar Bhatt
Archiv Der Pharmazie|August 25, 2025
Exploring Thioredoxin-Interacting Protein (TXNIP) as a Therapeutic Target for Cardiovascular DiseasesShrutika Date, Lokesh Kumar Bhatt
European Journal of Pharmacology|September 20, 2020
Evolving targets for anti-epileptic drug discoveryDezaree Raut, Lokesh Kumar Bhatt
Inflammopharmacology|November 18, 2021
Deubiquitylating enzymes: potential target in autoimmune diseasesNiraj Parihar, Lokesh Kumar Bhatt
Neurochemical Research|July 26, 2024
Targeting Adipokines: A Promising Therapeutic Strategy for EpilepsyIqraa Shaikh, Lokesh Kumar Bhatt
European Journal of Pharmacology|October 22, 2023
Emerging therapeutic avenues in cardiac amyloidosisVaishnavi Golatkar, Lokesh Kumar Bhatt
Current Molecular Pharmacology|June 2, 2023
Targeting Cellular Senescence: A Potential Therapeutic approach for Alzheimer's DiseaseShrishti Singh, Lokesh Kumar Bhatt
Advanced Biology|February 18, 2026
Emerging Therapeutic Targets and Signaling Networks in Ischemia-Reperfusion InjuryShreeya Bhujbal, Lokesh Kumar Bhatt
Current Molecular Pharmacology|December 1, 2021
Caveolin-1: A Promising Therapeutic Target for Diverse DiseasesShivani Gokani, Lokesh Kumar Bhatt
European Journal of Pharmacology|September 26, 2021
Bromodomains: A novel target for the anticancer therapyShivani Gokani, Lokesh Kumar Bhatt
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Inflammopharmacology|January 31, 2026
Cannabinoid type 2 receptor crosstalk and microglial plasticity-shaping the balance between neuroinflammation and repairShlok Bodke, Lokesh Kumar Bhatt
Archiv Der Pharmazie|August 25, 2025
Exploring Thioredoxin-Interacting Protein (TXNIP) as a Therapeutic Target for Cardiovascular DiseasesShrutika Date, Lokesh Kumar Bhatt
European Journal of Pharmacology|September 20, 2020
Evolving targets for anti-epileptic drug discoveryDezaree Raut, Lokesh Kumar Bhatt
Inflammopharmacology|November 18, 2021
Deubiquitylating enzymes: potential target in autoimmune diseasesNiraj Parihar, Lokesh Kumar Bhatt
Neurochemical Research|July 26, 2024
Targeting Adipokines: A Promising Therapeutic Strategy for EpilepsyIqraa Shaikh, Lokesh Kumar Bhatt
European Journal of Pharmacology|October 22, 2023
Emerging therapeutic avenues in cardiac amyloidosisVaishnavi Golatkar, Lokesh Kumar Bhatt
Current Molecular Pharmacology|June 2, 2023
Targeting Cellular Senescence: A Potential Therapeutic approach for Alzheimer's DiseaseShrishti Singh, Lokesh Kumar Bhatt
Advanced Biology|February 18, 2026
Emerging Therapeutic Targets and Signaling Networks in Ischemia-Reperfusion InjuryShreeya Bhujbal, Lokesh Kumar Bhatt
Current Molecular Pharmacology|December 1, 2021
Caveolin-1: A Promising Therapeutic Target for Diverse DiseasesShivani Gokani, Lokesh Kumar Bhatt
European Journal of Pharmacology|September 26, 2021
Bromodomains: A novel target for the anticancer therapyShivani Gokani, Lokesh Kumar Bhatt
Pageof 7